Validation of the Glasgow Admission Prediction Score in a Japanese Emergency Setting

在日本急诊环境下验证格拉斯哥入院预测评分

阅读:1

Abstract

INTRODUCTION: The Glasgow Admission Prediction Score (GAPS) is a triage tool that was developed in the United Kingdom to predict hospital admission based on available patient data upon arrival at emergency departments (EDs). Despite being associated with length of hospital stay, 6-month mortality, and readmission, its validity has only been assessed in the UK. Its generalizability therefore remains unclear. This study aimed to assess the predictive performance of the GAPS for short- and intermediate-term outcomes in a Japanese ED setting. METHODS: We conducted a retrospective cohort study of ambulance-transported ED visits between December 2020 and September 2023 at a Japanese general hospital. After excluding pediatric patients and those with missing or inconsistent data, 22,179 encounters were analyzed. GAPS scores were calculated upon ED arrival and stratified into tertiles. The outcomes included 30-day mortality, 30-day emergency re-transportation, 100-day hospital readmission, and length of inpatient stay. Kaplan-Meier and Cox proportional hazards analyses were performed. RESULTS: Higher GAPS scores were significantly associated with less favorable outcomes. Each 1-point increase was linked to a 10.3% increase in 30-day mortality risk (hazard ratio [HR] = 1.10; 95% confidence interval: 1.10-1.11), or a four-fold increase per 15-point rise (HR = 4.32). Similar associations were observed for re-transportation (HR = 1.03) and hospital readmission (HR = 1.09). Higher GAPS scores were also associated with longer hospital stays (HR for discharge = 0.98). CONCLUSION: GAPS presents a practical tool for predicting ambulance-transported ED encounter outcomes in Japan, although its broader applicability warrants further research.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。